标题
The renaissance of complement therapeutics
作者
关键词
-
出版物
Nature Reviews Nephrology
Volume 14, Issue 1, Pages 26-47
出版商
Springer Nature
发表日期
2017-12-04
DOI
10.1038/nrneph.2017.156
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Lupus nephritis and B-cell targeting therapy
- (2017) Matthias Cassia et al. Expert Review of Clinical Immunology
- Structure-Based Library Design and Fragment Screening for the Identification of Reversible Complement Factor D Protease Inhibitors
- (2017) Anna Vulpetti et al. JOURNAL OF MEDICINAL CHEMISTRY
- Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
- (2017) David R.W. Jayne et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Haemolytic uraemic syndrome
- (2017) Fadi Fakhouri et al. LANCET
- Complement in renal transplantation: The road to translation
- (2017) Neeltina M. Jager et al. MOLECULAR IMMUNOLOGY
- Kallikrein represents an independent complement activator
- (2017) Sarah Irmscher et al. MOLECULAR IMMUNOLOGY
- Activation of alternative complement pathway without complement factor D
- (2017) Yuzhou Zhang et al. MOLECULAR IMMUNOLOGY
- New concepts on the therapeutic control of complement anaphylatoxin receptors
- (2017) Owen A. Hawksworth et al. MOLECULAR IMMUNOLOGY
- Complement in clinical medicine: Clinical trials, case reports and therapy monitoring
- (2017) Daniel Ricklin et al. MOLECULAR IMMUNOLOGY
- Complement in ANCA-associated vasculitis: mechanisms and implications for management
- (2017) Min Chen et al. Nature Reviews Nephrology
- Cardiovascular disease in haemodialysis: role of the intravascular innate immune system
- (2017) Kristina N. Ekdahl et al. Nature Reviews Nephrology
- The role of the complement system in diabetic nephropathy
- (2017) Allan Flyvbjerg Nature Reviews Nephrology
- Redefining lupus nephritis: clinical implications of pathophysiologic subtypes
- (2017) Feng Yu et al. Nature Reviews Nephrology
- Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence
- (2017) Savino Sciascia et al. RHEUMATOLOGY INTERNATIONAL
- Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration
- (2017) Brian L. Yaspan et al. Science Translational Medicine
- Complement C3-Targeted Therapy: Replacing Long-Held Assertions with Evidence-Based Discovery
- (2017) Dimitrios C. Mastellos et al. TRENDS IN IMMUNOLOGY
- A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial
- (2017) Theodoros Kassimatis et al. Trials
- High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
- (2017) Lucy A. McNamara et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases
- (2017) Taku Fukuzawa et al. Scientific Reports
- PASylated Coversin, a C5-Specific Complement Inhibitor with Extended Pharmacokinetics, Shows Enhanced Anti-Hemolytic Activity in Vitro
- (2016) Nadine Kuhn et al. BIOCONJUGATE CHEMISTRY
- Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation
- (2016) Markus J. Harder et al. BLOOD
- Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40
- (2016) Junxiang Wang et al. CLINICAL IMMUNOLOGY
- A healthy female with C3 hypocomplementemia and C3 Nephritic Factor
- (2016) Maureen Egan et al. CLINICAL IMMUNOLOGY
- All Things Complement
- (2016) Joshua M. Thurman et al. Clinical Journal of the American Society of Nephrology
- The clinical potential of Affibody-based inhibitors of C5 for therapeutic complement disruption
- (2016) Magnus M. Berglund et al. Expert Review of Proteomics
- Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
- (2016) Xuan Yuan et al. HAEMATOLOGICA
- Role of the lectin complement pathway in kidney transplantation
- (2016) Conrad A. Farrar et al. IMMUNOBIOLOGY
- The paradoxical roles of C1q and C3 in autoimmunity
- (2016) Diane Scott et al. IMMUNOBIOLOGY
- Design and preclinical characterization of ALXN1210: A next generation anti-C5 monoclonal antibody with improved pharmacokinetics and duration of action
- (2016) Douglas Sheridan et al. IMMUNOBIOLOGY
- Therapeutic control of complement activation at the level of the central component C3
- (2016) Daniel Ricklin et al. IMMUNOBIOLOGY
- The membrane attack complex as an inflammatory trigger
- (2016) B. Paul Morgan IMMUNOBIOLOGY
- Preformed mediators of defense-Gatekeepers enter the spotlight
- (2016) Daniel Ricklin et al. IMMUNOLOGICAL REVIEWS
- The “ins and outs” of complement-driven immune responses
- (2016) Simon Freeley et al. IMMUNOLOGICAL REVIEWS
- Complement in removal of the dead - balancing inflammation
- (2016) Myriam Martin et al. IMMUNOLOGICAL REVIEWS
- Endothelial cells: source, barrier, and target of defensive mediators
- (2016) Lubka T. Roumenina et al. IMMUNOLOGICAL REVIEWS
- A journey through the lectin pathway of complement-MBL and beyond
- (2016) Peter Garred et al. IMMUNOLOGICAL REVIEWS
- Dangerous liaisons: complement, coagulation, and kallikrein/kinin cross-talk act as a linchpin in the events leading to thromboinflammation
- (2016) Kristina N. Ekdahl et al. IMMUNOLOGICAL REVIEWS
- Properdin: a tightly regulated critical inflammatory modulator
- (2016) Adam Z. Blatt et al. IMMUNOLOGICAL REVIEWS
- Protection of host cells by complement regulators
- (2016) Christoph Q. Schmidt et al. IMMUNOLOGICAL REVIEWS
- Complement component C3 - The “Swiss Army Knife” of innate immunity and host defense
- (2016) Daniel Ricklin et al. IMMUNOLOGICAL REVIEWS
- Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3
- (2016) Tomoki Maekawa et al. JOURNAL OF CLINICAL PERIODONTOLOGY
- Infections Revealing Complement Deficiency in Adults
- (2016) A. Audemard-Verger et al. MEDICINE
- Can eculizumab be discontinued in aHUS?
- (2016) Tuncay Sahutoglu et al. MEDICINE
- Small-molecule factor D inhibitors targeting the alternative complement pathway
- (2016) Jürgen Maibaum et al. Nature Chemical Biology
- The road less traveled: Start-ups invest in novel approaches against neurodegeneration
- (2016) Shraddha Chakradhar NATURE MEDICINE
- Complement in disease: a defence system turning offensive
- (2016) Daniel Ricklin et al. Nature Reviews Nephrology
- Complement and microglia mediate early synapse loss in Alzheimer mouse models
- (2016) S. Hong et al. SCIENCE
- Complement inhibition in C3 glomerulopathy
- (2016) Carla M. Nester et al. SEMINARS IN IMMUNOLOGY
- Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies
- (2016) Ronald P. Taylor et al. SEMINARS IN IMMUNOLOGY
- Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future
- (2016) Antonio M. Risitano et al. SEMINARS IN IMMUNOLOGY
- Complement inhibition in pre-clinical models of periodontitis and prospects for clinical application
- (2016) George Hajishengallis et al. SEMINARS IN IMMUNOLOGY
- New milestones ahead in complement-targeted therapy
- (2016) Daniel Ricklin et al. SEMINARS IN IMMUNOLOGY
- Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions
- (2016) Faith H. Brennan et al. SEMINARS IN IMMUNOLOGY
- A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface
- (2016) Rob N. de Jong et al. PLOS BIOLOGY
- Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
- (2016) Xuan Yuan et al. HAEMATOLOGICA
- IgA nephropathy
- (2016) Kar Neng Lai et al. Nature Reviews Disease Primers
- MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linked
- (2016) József Dobó et al. Scientific Reports
- Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015
- (2015) Marina Noris et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Complement in Kidney Disease: Core Curriculum 2015
- (2015) Joshua M. Thurman AMERICAN JOURNAL OF KIDNEY DISEASES
- Positive Crossmatch Kidney Transplant Recipients Treated With Eculizumab: Outcomes Beyond 1 Year
- (2015) L. D. Cornell et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII
- (2015) A. Yee et al. BLOOD
- Complement C3dg-mediated erythrophagocytosis: implications for paroxysmal nocturnal hemoglobinuria
- (2015) Z. Lin et al. BLOOD
- Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention
- (2015) Dimitrios C. Mastellos et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathy
- (2015) Yuzhou Zhang et al. IMMUNOBIOLOGY
- Therapeutic C3 inhibitor Cp40 abrogates complement activation induced by modern hemodialysis filters
- (2015) Edimara S. Reis et al. IMMUNOBIOLOGY
- Rare Loss-of-Function Mutation in Complement Component C3 Provides Insight into Molecular and Pathophysiological Determinants of Complement Activity
- (2015) Georgia Sfyroera et al. JOURNAL OF IMMUNOLOGY
- The role of genetically engineered pigs in xenotransplantation research
- (2015) David KC Cooper et al. JOURNAL OF PATHOLOGY
- The emerging role of complement inhibitors in transplantation
- (2015) Véronique Frémeaux-Bacchi et al. KIDNEY INTERNATIONAL
- Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies
- (2015) Christoph Licht et al. KIDNEY INTERNATIONAL
- The role of complement in C3 glomerulopathy
- (2015) Peter F. Zipfel et al. MOLECULAR IMMUNOLOGY
- Atypical aHUS: State of the art
- (2015) Carla M. Nester et al. MOLECULAR IMMUNOLOGY
- Complement, a target for therapy in inflammatory and degenerative diseases
- (2015) B. Paul Morgan et al. NATURE REVIEWS DRUG DISCOVERY
- Platelets and the complement cascade in atherosclerosis
- (2015) Johannes Patzelt et al. Frontiers in Physiology
- Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria
- (2014) Antonio M. Risitano et al. BLOOD
- Opportunity Cost of Funding Drugs for Rare Diseases
- (2014) Doug Coyle et al. MEDICAL DECISION MAKING
- Genetic Variants in C5 and Poor Response to Eculizumab
- (2014) Jun-ichi Nishimura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief
- (2014) Alessio Moriconi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
- (2014) C. A. Diebolder et al. SCIENCE
- Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
- (2013) Peter Hillmen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Complement activation in diseases presenting with thrombotic microangiopathy
- (2013) Seppo Meri European Journal of Internal Medicine
- Rational Engineering of a Minimized Immune Inhibitor with Unique Triple-Targeting Properties
- (2013) C. Q. Schmidt et al. JOURNAL OF IMMUNOLOGY
- Soluble CR1 Therapy Improves Complement Regulation in C3 Glomerulopathy
- (2013) Y. Zhang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN
- (2013) H. Xiao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Eculizumab for atypical haemolytic uraemic syndrome: what next?
- (2013) Fadi Fakhouri et al. Nature Reviews Nephrology
- The role of the complement system in metabolic organs and metabolic diseases
- (2013) Julia Phieler et al. SEMINARS IN IMMUNOLOGY
- The Complement System: An Unexpected Role in Synaptic Pruning During Development and Disease
- (2012) Alexander H. Stephan et al. Annual Review of Neuroscience
- Autoregulation of thromboinflammation on biomaterial surfaces by a multicomponent therapeutic coating
- (2012) Per H. Nilsson et al. BIOMATERIALS
- The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment
- (2012) A. M. Risitano et al. BLOOD
- Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis
- (2012) A. S. Bomback et al. Clinical Journal of the American Society of Nephrology
- Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis
- (2012) Robert A. DeAngelis et al. IMMUNOBIOLOGY
- New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties
- (2012) Hongchang Qu et al. IMMUNOBIOLOGY
- Inhibiting Alternative Pathway Complement Activation by Targeting the Factor D Exosite
- (2012) Kenneth J. Katschke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role of complement in antibody-mediated rejection in kidney transplantation
- (2012) Mark D. Stegall et al. Nature Reviews Nephrology
- STEC-HUS, atypical HUS and TTP are all diseases of complement activation
- (2012) Marina Noris et al. Nature Reviews Nephrology
- The complotype: dictating risk for inflammation and infection
- (2012) Claire L. Harris et al. TRENDS IN IMMUNOLOGY
- Innate immunity activation on biomaterial surfaces: A mechanistic model and coping strategies
- (2011) Kristina N. Ekdahl et al. ADVANCED DRUG DELIVERY REVIEWS
- Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients
- (2011) M. D. Stegall et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Protection of Nonself Surfaces from Complement Attack by Factor H-Binding Peptides: Implications for Therapeutic Medicine
- (2011) You-Qiang Wu et al. JOURNAL OF IMMUNOLOGY
- Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury
- (2011) W. J. Schwaeble et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- C1-Inhibitor: More Than a Serine Protease Inhibitor
- (2011) Sacha Zeerleder SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Systemic Complement Activation in Deceased Donors Is Associated With Acute Rejection After Renal Transplantation in the Recipient
- (2011) Jeffrey Damman et al. TRANSPLANTATION
- Binding of mannose-binding lectin to fructosamines: a potential link between hyperglycaemia and complement activation in diabetes
- (2010) Juliette Fortpied et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation
- (2010) F. Forneris et al. SCIENCE
- Taking Complement to the Clinic - has the Time Finally Come?
- (2009) P. J. Lachmann et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- C5a Receptor Mediates Neutrophil Activation and ANCA-Induced Glomerulonephritis
- (2008) A. Schreiber et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started